The Medicine Maker
  • Explore

    Explore

    • Latest
    • Features
    • Interviews
    • Business & Trends
    • Technology & Manufacturing
    • Product Profiles
    • White Papers

    Featured Topics

    • Biopharma
    • Small Molecules
    • Cell & Gene
    • Future of Pharma

    Issues

    • Latest Issue
    • Archive
    • Cell and Gene Therapy Supplement
  • Topics

    Topics

    • Cell & Gene
    • Bioprocessing
    • Drug Delivery
    • Drug Discovery
    • Development & Clinical
    • Formulation
    • Facilities & Equipment
    • Outsourcing
    • Packaging
    • Regulation & Standards
    • Small Molecules
    • Supply Chain
  • News & Blogs

    News & Blogs

    • Industry News
    • Research News
    • Blogs
  • Events
    • Live Events
    • Webinars
  • Community & Awards

    Community & Awards

    • Power List
    • Sitting Down With
    • Innovation Awards
    • Company of the Year Awards
    • Authors & Contributors
  • Multimedia
    • Video
    • eBooks
    • Content Hubs
Subscribe
Subscribe
The Medicine Maker / Issues / 2026 / July / Moving Beyond Document-Based Validation
Bioprocessing Interviews Regulation & Standards Standards & Regulation Quality & Compliance Technology & Manufacturing Sponsored

Moving Beyond Document-Based Validation

How UCB is improving traceability, audit readiness, and visibility.

07/02/2026 1 min read Video

Share

Slow workflows, fragmented tools, and repeated data entry can make global validation harder to manage and inspections more difficult to prepare for. How can companies create a faster, more traceable process without simply digitizing existing inefficiencies?

Nadia Williams, Head of IT Compliance Solutions at UCB, explains how the company is moving toward a centralized, record-based validation platform. She also discusses UCB’s pilot-led approach to change, ensuring standardization and audit readiness, and the future potential of automation and AI.

Watch the interview.

Newsletters

Receive the latest pharmaceutical news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

Recommended

Related Content

What Pharma Can Learn From Military Intelligence
Interviews Business & Trends
What Pharma Can Learn From Military Intelligence

August 21, 2026

5 min read

Former military intelligence officer Tony Page discusses what pharma can learn from early warning systems, decision cycles, and the discipline of intelligence

Musings from The Power List: Daniel Vitt
Small Molecules Drug Discovery Development & Clinical
Musings from The Power List: Daniel Vitt

August 20, 2026

6 min read

From multiple sclerosis to AI-driven discovery, Daniel Vitt reflects on the future of drug development

The Road to Commercial-Scale iPSC Cell Therapy
Cell & Gene Development & Clinical Interviews
The Road to Commercial-Scale iPSC Cell Therapy

August 19, 2026

5 min read

Can iPSC platforms deliver consistent, commercial-scale cell therapies for large patient populations?

The Mindset for Success in Biopharma's New Multipolar World
Biopharma Development & Clinical Outsourcing
The Mindset for Success in Biopharma's New Multipolar World

August 18, 2026

10 min read

From collapsing legacy models to the rise of Chinese biotech, industry leaders are being forced to rethink how drugs are developed, funded, and brought to market

The Medicine Maker
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Affiliations:

Specialties:

Areas of Expertise:

Contributions: